en
Scientific article
Open access
English

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Published inRMD open, vol. 1, no. 1, e000040
Publication date2015
Abstract

There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) retention in patients with rheumatoid arthritis (RA) treated in clinical practice.

Citation (ISO format)
FINCKH, Axel et al. The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. In: RMD open, 2015, vol. 1, n° 1, p. e000040. doi: 10.1136/rmdopen-2014-000040
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal2056-5933
394views
164downloads

Technical informations

Creation08/31/2016 10:52:00 AM
First validation08/31/2016 10:52:00 AM
Update time03/15/2023 12:48:20 AM
Status update03/15/2023 12:48:19 AM
Last indexation08/30/2023 9:45:18 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack